Comparison of Atomoxetine Versus Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)

NCT00546910 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

125

Enrollment

INDUSTRY

Sponsor class

Conditions

Attention Deficit Hyperactivity Disorder

Interventions

DRUG: Atomoxetine
DRUG: Placebo

Sponsor

Eli Lilly and Company